Acute coronary syndromes Randomized to a Controlled evaluation in the first Hours of presentation with Irbesartan vs. enalapril to Prevent Elevated inflammation, Limit myocardial ischemia And Generate better Outcome - ARCHIPELAGO


The goal of the trial was to evaluate treatment with irbesartan compared with enalapril (and early versus late treatment) among patients with non-ST-elevation acute coronary syndromes (NSTE-ACS).